Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 115

1.

Histological features of medullary carcinoma and prognosis in triple-negative basal-like carcinomas of the breast.

Marginean F, Rakha EA, Ho BC, Ellis IO, Lee AH.

Mod Pathol. 2010 Oct;23(10):1357-63. doi: 10.1038/modpathol.2010.123. Epub 2010 Jun 25.

PMID:
20581807
[PubMed - indexed for MEDLINE]
Free Article
2.

Inference of the Basal epithelial phenotype in breast carcinoma from differential marker expression, using tissue microarrays in triple negative breast cancer and women younger than 35.

Nassar A, Sussman ZM, Lawson D, Cohen C.

Breast J. 2012 Sep;18(5):399-405. doi: 10.1111/j.1524-4741.2012.01279.x. Epub 2012 Aug 10.

PMID:
22882580
[PubMed - indexed for MEDLINE]
3.

Estrogen receptor-beta expression in invasive breast cancer in relation to molecular phenotype: results from the Nurses' Health Study.

Marotti JD, Collins LC, Hu R, Tamimi RM.

Mod Pathol. 2010 Feb;23(2):197-204. doi: 10.1038/modpathol.2009.158. Epub 2009 Nov 6.

PMID:
19898422
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Characteristics of basal cytokeratin expression in breast cancer.

Alshareeda AT, Soria D, Garibaldi JM, Rakha E, Nolan C, Ellis IO, Green AR.

Breast Cancer Res Treat. 2013 May;139(1):23-37. doi: 10.1007/s10549-013-2518-x. Epub 2013 Apr 16.

PMID:
23588953
[PubMed - indexed for MEDLINE]
5.

The expression of cytokeratin 5/6 in invasive lobular carcinoma of the breast: evidence of a basal-like subset?

Fadare O, Wang SA, Hileeto D.

Hum Pathol. 2008 Mar;39(3):331-6. doi: 10.1016/j.humpath.2007.07.014.

PMID:
18261623
[PubMed - indexed for MEDLINE]
6.

Sporadic invasive breast carcinomas with medullary features display a basal-like phenotype: an immunohistochemical and gene amplification study.

Rodríguez-Pinilla SM, Rodríguez-Gil Y, Moreno-Bueno G, Sarrió D, Martín-Guijarro Mdel C, Hernandez L, Palacios J.

Am J Surg Pathol. 2007 Apr;31(4):501-8.

PMID:
17414096
[PubMed - indexed for MEDLINE]
7.

Basal-like breast cancer defined by five biomarkers has superior prognostic value than triple-negative phenotype.

Cheang MC, Voduc D, Bajdik C, Leung S, McKinney S, Chia SK, Perou CM, Nielsen TO.

Clin Cancer Res. 2008 Mar 1;14(5):1368-76. doi: 10.1158/1078-0432.CCR-07-1658.

PMID:
18316557
[PubMed - indexed for MEDLINE]
Free Article
8.

Morphological and immunophenotypic analysis of breast carcinomas with basal and myoepithelial differentiation.

Rakha EA, Putti TC, Abd El-Rehim DM, Paish C, Green AR, Powe DG, Lee AH, Robertson JF, Ellis IO.

J Pathol. 2006 Mar;208(4):495-506.

PMID:
16429394
[PubMed - indexed for MEDLINE]
9.

Prognostic markers in triple-negative breast cancer.

Rakha EA, El-Sayed ME, Green AR, Lee AH, Robertson JF, Ellis IO.

Cancer. 2007 Jan 1;109(1):25-32.

PMID:
17146782
[PubMed - indexed for MEDLINE]
Free Article
10.

Basal cytokeratin expression in relation to immunohistochemical and clinical characterization in breast cancer patients with triple negative phenotype.

Liu ZB, Wu J, Ping B, Feng LQ, Di GH, Lu JS, Shen KW, Shen ZZ, Shaol ZM.

Tumori. 2009 Jan-Feb;95(1):53-62.

PMID:
19366057
[PubMed - indexed for MEDLINE]
11.

Basal phenotype of ductal carcinoma in situ: recognition and immunohistologic profile.

Dabbs DJ, Chivukula M, Carter G, Bhargava R.

Mod Pathol. 2006 Nov;19(11):1506-11. Epub 2006 Aug 25.

PMID:
16941011
[PubMed - indexed for MEDLINE]
Free Article
12.

Ductal carcinoma in situ with basal-like phenotype: a possible precursor to invasive basal-like breast cancer.

Bryan BB, Schnitt SJ, Collins LC.

Mod Pathol. 2006 May;19(5):617-21.

PMID:
16528377
[PubMed - indexed for MEDLINE]
Free Article
13.

The prognostic significance of inflammation and medullary histological type in invasive carcinoma of the breast.

Rakha EA, Aleskandarany M, El-Sayed ME, Blamey RW, Elston CW, Ellis IO, Lee AH.

Eur J Cancer. 2009 Jul;45(10):1780-7. doi: 10.1016/j.ejca.2009.02.014. Epub 2009 Mar 14.

PMID:
19286369
[PubMed - indexed for MEDLINE]
14.

Triple negative breast cancer: a study from the point of view of basal CK5/6 and HER-1.

Pintens S, Neven P, Drijkoningen M, Van Belle V, Moerman P, Christiaens MR, Smeets A, Wildiers H, Vanden Bempt I.

J Clin Pathol. 2009 Jul;62(7):624-8. doi: 10.1136/jcp.2008.061358.

PMID:
19561231
[PubMed - indexed for MEDLINE]
15.

[Morphological features of basal-like subtype invasive carcinoma of breast].

Gao LX, Yang GZ, Ding HY, Li L.

Zhonghua Bing Li Xue Za Zhi. 2008 Feb;37(2):83-7. Chinese.

PMID:
18681317
[PubMed - indexed for MEDLINE]
16.

Clinicopathologic significance of the basal-like subtype of breast cancer: a comparison with hormone receptor and Her2/neu-overexpressing phenotypes.

Kim MJ, Ro JY, Ahn SH, Kim HH, Kim SB, Gong G.

Hum Pathol. 2006 Sep;37(9):1217-26. Epub 2006 Jul 18.

PMID:
16938528
[PubMed - indexed for MEDLINE]
17.

Basal cytokeratin and epidermal growth factor receptor expression are not predictive of BRCA1 mutation status in women with triple-negative breast cancers.

Collins LC, Martyniak A, Kandel MJ, Stadler ZK, Masciari S, Miron A, Richardson AL, Schnitt SJ, Garber JE.

Am J Surg Pathol. 2009 Jul;33(7):1093-7. doi: 10.1097/PAS.0b013e31819c1c93.

PMID:
19390427
[PubMed - indexed for MEDLINE]
18.

Breast carcinoma with basal differentiation: a proposal for pathology definition based on basal cytokeratin expression.

Rakha EA, El-Sayed ME, Green AR, Paish EC, Lee AH, Ellis IO.

Histopathology. 2007 Mar;50(4):434-8.

PMID:
17448018
[PubMed - indexed for MEDLINE]
19.

[Basal and myoepithelial phenotype of metastatic mammary carcinomas. A prognostic factor in the palliative situation?].

Mainka P, Kahlert S, Kirchner T, Mayr D, Diebold J.

Pathologe. 2008 Nov;29 Suppl 2:363-9. doi: 10.1007/s00292-008-1032-0. German.

PMID:
18807040
[PubMed - indexed for MEDLINE]
20.

The immunohistochemically "ER-negative, PR-negative, HER2-negative, CK5/6-negative, and HER1-negative" subgroup is not a surrogate for the normal-like subtype in breast cancer.

Yu KD, Shen ZZ, Shao ZM.

Breast Cancer Res Treat. 2009 Dec;118(3):661-3. doi: 10.1007/s10549-009-0522-y. No abstract available.

PMID:
19714461
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk